{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:49:03Z","timestamp":1794563343223,"version":"4.9.1"},"reference-count":217,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-020-00227-0","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T04:03:04Z","timestamp":1606968184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":925,"title":["Allergic rhinitis"],"prefix":"10.1038","volume":"6","author":[{"given":"Jean","family":"Bousquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Anto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Baiardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinthia","family":"Bosnic-Anticevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Walter Canonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Mel\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Palomares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenis K.","family":"Scadding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkis","family":"Togias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna","family":"Toppila-Salmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"issue":"Suppl. 86","key":"227_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","volume":"63","author":"J Bousquet","year":"2008","unstructured":"Bousquet, J. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy 63 (Suppl. 86), 8\u2013160 (2008). ARIA is a non-governmental organization that collaborated with the WHO. This authoritative review provides evidence that most patients with asthma have multimorbid rhinitis, whereas less than one-third of patients with AR have multimorbid asthma.","journal-title":"Allergy"},{"key":"227_CR2","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(11)60130-X","volume":"378","author":"AN Greiner","year":"2011","unstructured":"Greiner, A. N., Hellings, P. W., Rotiroti, G. & Scadding, G. K. Allergic rhinitis. Lancet 378, 2112\u20132122 (2011).","journal-title":"Lancet"},{"key":"227_CR3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1398-9995.2008.01824.x","volume":"63","author":"PJ Bousquet","year":"2008","unstructured":"Bousquet, P. J. et al. Geographical distribution of atopic rhinitis in the European community respiratory health survey I. Allergy 63, 1301\u20131309 (2008).","journal-title":"Allergy"},{"key":"227_CR4","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jaip.2017.09.002","volume":"6","author":"O Vandenplas","year":"2018","unstructured":"Vandenplas, O. et al. Impact of rhinitis on work productivity: a systematic review. J Allergy Clin. Immunol. Pract. 6, 1274\u20131286 (2018).","journal-title":"J Allergy Clin. Immunol. Pract."},{"key":"227_CR5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/cea.12801","volume":"46","author":"P Devillier","year":"2016","unstructured":"Devillier, P. et al. In allergic rhinitis, work, classroom and activity impairments are weakly related to other outcome measures. Clin. Exp. Allergy 46, 1456\u20131464 (2016).","journal-title":"Clin. Exp. Allergy"},{"key":"227_CR6","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/all.12470","volume":"69","author":"T Zuberbier","year":"2014","unstructured":"Zuberbier, T., Lotvall, J., Simoens, S., Subramanian, S. V. & Church, M. K. Economic burden of inadequate management of allergic diseases in the European Union: a GA2LEN review. Allergy 69, 1275\u20131279 (2014).","journal-title":"Allergy"},{"key":"227_CR7","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/all.13099","volume":"72","author":"C Colas","year":"2017","unstructured":"Colas, C. et al. Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN study. Allergy 72, 959\u2013966 (2017).","journal-title":"Allergy"},{"key":"227_CR8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(06)69283-0","volume":"368","author":"MI Asher","year":"2006","unstructured":"Asher, M. I. et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 368, 733\u2013743 (2006). ISAAC is the largest global prevalence study of allergic diseases. Its results have shown that AR prevalence increases from childhood to adolescence. From the 1990s to the early years of the first decade of the twenty-first century, prevalence was still increasing in many developing countries.","journal-title":"Lancet"},{"key":"227_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1398-9995.2008.01884.x","volume":"64","author":"N Ait-Khaled","year":"2009","unstructured":"Ait-Khaled, N. et al. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: the international study of asthma and allergies in childhood (ISAAC) phase three. Allergy 64, 123\u2013148 (2009).","journal-title":"Allergy"},{"key":"227_CR10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.13312","volume":"73","author":"T Keller","year":"2018","unstructured":"Keller, T. et al. The sex-shift in single disease and multimorbid asthma and rhinitis during puberty - a study by MeDALL. Allergy 73, 602\u2013614 (2018).","journal-title":"Allergy"},{"key":"227_CR11","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jaci.2010.06.050","volume":"126","author":"K Singh","year":"2010","unstructured":"Singh, K., Axelrod, S. & Bielory, L. The epidemiology of ocular and nasal allergy in the United States, 1988\u20131994. J. Allergy Clin. Immunol. 126, 778\u2013783 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR12","first-page":"11","volume":"230","author":"J Latvala","year":"2005","unstructured":"Latvala, J., von Hertzen, L., Lindholm, H. & Haahtela, T. Trends in prevalence of asthma and allergy in Finnish young men: nationwide study, 1966\u20132003. BMJ 230, 11\u201386\u201387 (2005).","journal-title":"BMJ"},{"key":"227_CR13","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1056\/NEJMra054308","volume":"355","author":"W Eder","year":"2006","unstructured":"Eder, W., Ege, M. J. & von Mutius, E. The asthma epidemic. N. Engl. J. Med. 355, 2226\u20132235 (2006).","journal-title":"N. Engl. J. Med."},{"key":"227_CR14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMcp1412282","volume":"372","author":"LM Wheatley","year":"2015","unstructured":"Wheatley, L. M. & Togias, A. Allergic rhinitis. N. Engl. J. Med. 372, 456\u2013463 (2015).","journal-title":"N. Engl. J. Med."},{"key":"227_CR15","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1398-9995.2008.01801.x","volume":"63","author":"G Moscato","year":"2008","unstructured":"Moscato, G. et al. Occupational rhinitis. Allergy 63, 969\u2013980 (2008).","journal-title":"Allergy"},{"key":"227_CR16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1465-9921-11-8","volume":"11","author":"MI Asher","year":"2010","unstructured":"Asher, M. I. et al. Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One. Respir. Res. 11, 8 (2010).","journal-title":"Respir. Res."},{"key":"227_CR17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/ACI.0000000000000504","volume":"19","author":"H Tajima","year":"2019","unstructured":"Tajima, H. & Pawankar, R. Obesity and adiposity indicators in asthma and allergic rhinitis in children. Curr. Opin. Allergy Clin. Immunol. 19, 7\u201311 (2019).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"227_CR18","first-page":"108","volume":"8","author":"SK Wise","year":"2018","unstructured":"Wise, S. K. et al. International consensus statement on allergy and rhinology: allergic rhinitis. Int. Forum Allergy Rhinol. 8, 108\u2013352 (2018). In this critical review of the AR literature, the authors apply a systematic evidence-based approach to provide a comprehensive, clinical update on current knowledge of AR and to identify knowledge gaps for future studies.","journal-title":"Int. Forum Allergy Rhinol."},{"key":"227_CR19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jaci.2019.11.040","volume":"145","author":"E Burte","year":"2020","unstructured":"Burte, E. et al. Long-term air pollution exposure is associated with increased severity of rhinitis in 2 European cohorts. J. Allergy Clin. Immunol. 145, 834\u2013842 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0895-4356(03)00043-X","volume":"56","author":"A Zacharasiewicz","year":"2003","unstructured":"Zacharasiewicz, A., Douwes, J. & Pearce, N. What proportion of rhinitis symptoms is attributable to atopy? J. Clin. Epidemiol. 56, 385\u2013390 (2003).","journal-title":"J. Clin. Epidemiol."},{"key":"227_CR21","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/ng.3985","volume":"49","author":"MA Ferreira","year":"2017","unstructured":"Ferreira, M. A. et al. Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology. Nat. Genet. 49, 1752\u20131757 (2017). This landmark GWAS on allergic multimorbidity strongly suggest that asthma, hay fever and eczema partly coexist because they share many genetic risk variants that dysregulate the expression of immune-related genes.","journal-title":"Nat. Genet."},{"key":"227_CR22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jaci.2016.12.940","volume":"139","author":"JM Anto","year":"2017","unstructured":"Anto, J. M. et al. Mechanisms of the Development of Allergy (MeDALL): introducing novel concepts in allergy phenotypes. J. Allergy Clin. Immunol. 139, 388\u2013399 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/ACI.0000000000000124","volume":"15","author":"J Li","year":"2015","unstructured":"Li, J., Zhang, Y. & Zhang, L. Discovering susceptibility genes for allergic rhinitis and allergy using a genome-wide association study strategy. Curr. Opin. Allergy Clin. Immunol. 15, 33\u201340 (2015).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"227_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/all.14314","author":"N Lemonnier","year":"2020","unstructured":"Lemonnier, N. et al. A novel whole blood gene expression signature for asthma, dermatitis, and rhinitis multimorbidity in children and adolescents. Allergy https:\/\/doi.org\/10.1111\/all.14314 (2020). This MeDALL collaborative study represents the largest transcriptomics allergy dataset published to date and describes unique blood gene expression signatures in allergic multimorbidity versus rhinitis only.","journal-title":"Allergy"},{"key":"227_CR25","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/s41588-018-0157-1","volume":"50","author":"J Waage","year":"2018","unstructured":"Waage, J. et al. Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis. Nat. Genet. 50, 1072\u20131080 (2018).","journal-title":"Nat. Genet."},{"key":"227_CR26","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jaci.2016.03.010","volume":"137","author":"A Muraro","year":"2016","unstructured":"Muraro, A. et al. Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J. Allergy Clin. Immunol. 137, 1347\u20131358 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/pai.13027","volume":"30","author":"N Bougas","year":"2019","unstructured":"Bougas, N. et al. Unsupervised trajectories of respiratory\/allergic symptoms throughout childhood in the PARIS cohort. Pediatr. Allergy Immunol. 30, 315\u2013324 (2019).","journal-title":"Pediatr. Allergy Immunol."},{"key":"227_CR28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S2213-2600(13)70277-7","volume":"2","author":"M Pinart","year":"2014","unstructured":"Pinart, M. et al. Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study. Lancet Respir. Med. 2, 131\u2013140 (2014). The MeDALL study is the first to quantify the net excess of multimorbidity asthma, eczema and AR both in the presence and in the absence of IgE sensitization. It shows that multimorbidity is not occurring by chance.","journal-title":"Lancet Respir. Med."},{"key":"227_CR29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4168\/aair.2015.7.1.44","volume":"7","author":"F Cibella","year":"2015","unstructured":"Cibella, F. et al. The burden of rhinitis and rhinoconjunctivitis in adolescents. Allergy Asthma Immunol. Res. 7, 44\u201350 (2015).","journal-title":"Allergy Asthma Immunol. Res."},{"key":"227_CR30","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/all.13676","volume":"74","author":"V Siroux","year":"2019","unstructured":"Siroux, V. et al. Association between asthma, rhinitis, and conjunctivitis multimorbidities with molecular IgE sensitization in adults. Allergy 74, 824\u2013827 (2019).","journal-title":"Allergy"},{"key":"227_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/all.13971","author":"S Toppila-Salmi","year":"2019","unstructured":"Toppila-Salmi, S. et al. Risk of adult-onset asthma increases with the number of allergic multimorbidities and decreases with age. Allergy https:\/\/doi.org\/10.1111\/all.13971 (2019).","journal-title":"Allergy"},{"key":"227_CR32","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/all.13448","volume":"73","author":"J Bousquet","year":"2018","unstructured":"Bousquet, J. et al. Daily allergic multimorbidity in rhinitis using mobile technology: a novel concept of the MASK study. Allergy 73, 1622\u20131631 (2018).","journal-title":"Allergy"},{"key":"227_CR33","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/all.13670","volume":"74","author":"R Amaral","year":"2019","unstructured":"Amaral, R. et al. Disentangling the heterogeneity of allergic respiratory diseases by latent class analysis reveals novel phenotypes. Allergy 74, 698\u2013708 (2019).","journal-title":"Allergy"},{"key":"227_CR34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000498861","volume":"179","author":"J Jantunen","year":"2019","unstructured":"Jantunen, J. et al. Multimorbidity in asthma, allergic conditions and COPD increase disease severity, drug use and costs: the Finnish pharmacy survey. Int. Arch. Allergy Immunol. 179, 273\u2013280 (2019).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"227_CR35","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/all.12637","volume":"70","author":"J Bousquet","year":"2015","unstructured":"Bousquet, J. et al. Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesis. Allergy 70, 1062\u20131078 (2015).","journal-title":"Allergy"},{"key":"227_CR36","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/all.13410","volume":"73","author":"V Siroux","year":"2018","unstructured":"Siroux, V. et al. The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults. Allergy 73, 1447\u20131458 (2018).","journal-title":"Allergy"},{"key":"227_CR37","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/all.13133","volume":"72","author":"O Pfaar","year":"2017","unstructured":"Pfaar, O. et al. Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI position paper. Allergy 72, 1035\u20131042 (2017).","journal-title":"Allergy"},{"key":"227_CR38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2222.1987.tb02049.x","volume":"17","author":"J Bousquet","year":"1987","unstructured":"Bousquet, J. et al. Nasal challenge with pollen grains, skin-prick tests and specific IgE in patients with grass pollen allergy. Clin. Allergy 17, 529\u2013536 (1987).","journal-title":"Clin. Allergy"},{"key":"227_CR39","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.4049\/jimmunol.148.8.2390","volume":"148","author":"SR Durham","year":"1992","unstructured":"Durham, S. R. et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte\/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J. Immunol. 148, 2390\u20132394 (1992).","journal-title":"J. Immunol."},{"key":"227_CR40","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1164\/rccm.201502-0339OC","volume":"192","author":"AO Eifan","year":"2015","unstructured":"Eifan, A. O., Orban, N. T., Jacobson, M. R. & Durham, S. R. Severe persistent allergic rhinitis. Inflammation but no histologic features of structural upper airway remodeling. Am. J. Respir. Crit. Care Med. 192, 1431\u20131439 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"227_CR41","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jaci.2020.02.024","volume":"145","author":"D Larson","year":"2020","unstructured":"Larson, D. et al. Nasal allergen challenge and environmental exposure chamber challenge: a randomized trial comparing clinical and biological responses to cat allergen. J. Allergy Clin. Immunol. 145, 1585\u20131597 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1067\/mai.2000.107398","volume":"106","author":"L Cameron","year":"2000","unstructured":"Cameron, L. et al. Local synthesis of epsilon germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure. J. Allergy Clin. Immunol. 106, 46\u201352 (2000).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR43","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaci.2014.06.036","volume":"134","author":"BN Lambrecht","year":"2014","unstructured":"Lambrecht, B. N. & Hammad, H. Allergens and the airway epithelium response: gateway to allergic sensitization. J. Allergy Clin. Immunol. 134, 499\u2013507 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41590-018-0067-5","volume":"19","author":"C Cayrol","year":"2018","unstructured":"Cayrol, C. et al. Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33. Nat. Immunol. 19, 375\u2013385 (2018).","journal-title":"Nat. Immunol."},{"key":"227_CR45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2015.07.007","volume":"43","author":"H Hammad","year":"2015","unstructured":"Hammad, H. & Lambrecht, B. N. Barrier epithelial cells and the control of type 2 immunity. Immunity 43, 29\u201340 (2015).","journal-title":"Immunity"},{"key":"227_CR46","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI124606","volume":"129","author":"F Roan","year":"2019","unstructured":"Roan, F., Obata-Ninomiya, K. & Ziegler, S. F. Epithelial cell-derived cytokines: more than just signaling the alarm. J. Clin. Invest. 129, 1441\u20131451 (2019).","journal-title":"J. Clin. Invest."},{"key":"227_CR47","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.scitotenv.2018.10.188","volume":"652","author":"X Munoz","year":"2019","unstructured":"Munoz, X. et al. Diesel exhausts particles: their role in increasing the incidence of asthma. Reviewing the evidence of a causal link. Sci. Total Environ. 652, 1129\u20131138 (2019).","journal-title":"Sci. Total Environ."},{"key":"227_CR48","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jaci.2017.04.010","volume":"139","author":"RP Schleimer","year":"2017","unstructured":"Schleimer, R. P. & Berdnikovs, S. Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases. J. Allergy Clin. Immunol. 139, 1752\u20131761 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR49","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.molmed.2019.05.003","volume":"25","author":"AR Teufelberger","year":"2019","unstructured":"Teufelberger, A. R., Broker, B. M., Krysko, D. V., Bachert, C. & Krysko, O. Staphylococcus aureus orchestrates type 2 airway diseases. Trends Mol. Med. 25, 696\u2013707 (2019).","journal-title":"Trends Mol. Med."},{"key":"227_CR50","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jaip.2019.02.030","volume":"7","author":"M Humbert","year":"2019","unstructured":"Humbert, M. et al. IgE-mediated multimorbidities in allergic asthma and the potential for omalizumab therapy. J. Allergy Clin. Immunol. Pract. 7, 1418\u20131429 (2019). This is a compelling review about the role of IgE in the pathophysiology of allergic asthma and associated allergic multimorbidities, including AR.","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"227_CR51","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/imr.12555","volume":"278","author":"O Palomares","year":"2017","unstructured":"Palomares, O., Akdis, M., Martin-Fontecha, M. & Akdis, C. A. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. Immunol. Rev. 278, 219\u2013236 (2017). This is a comprehensive review discussing the role of regulatory T and B cells in the induction and maintenance of tolerance in allergic diseases, including AR. A deeper analysis of the molecular mechanism governing the generation of regulatory T cells and B cells in tolerance and discussion of how this could be exploited to develop alternative therapeutic interventions is also provided.","journal-title":"Immunol. Rev."},{"key":"227_CR52","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/ijms18061328","volume":"18","author":"O Palomares","year":"2017","unstructured":"Palomares, O. et al. dIvergEnt: how IgE axis contributes to the continuum of allergic asthma and anti-IgE therapies. Int. J. Mol. Sci. 18, 1328 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"227_CR53","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/all.13436","volume":"73","author":"F Ihara","year":"2018","unstructured":"Ihara, F. et al. Identification of specifically reduced Th2 cell subsets in allergic rhinitis patients after sublingual immunotherapy. Allergy 73, 1823\u20131832 (2018).","journal-title":"Allergy"},{"key":"227_CR54","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/all.13295","volume":"73","author":"T Iinuma","year":"2018","unstructured":"Iinuma, T. et al. Pathogenicity of memory Th2 cells is linked to stage of allergic rhinitis. Allergy 73, 479\u2013489 (2018).","journal-title":"Allergy"},{"key":"227_CR55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev-immunol-051116-052350","volume":"35","author":"T Nakayama","year":"2017","unstructured":"Nakayama, T. et al. Th2 cells in health and disease. Annu. Rev. Immunol. 35, 53\u201384 (2017).","journal-title":"Annu. Rev. Immunol."},{"key":"227_CR56","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1164\/ajrccm.151.1.7812543","volume":"151","author":"MC Lim","year":"1995","unstructured":"Lim, M. C., Taylor, R. M. & Naclerio, R. M. The histology of allergic rhinitis and its comparison to cellular changes in nasal lavage. Am. J. Respir. Crit. Care Med. 151, 136\u2013144 (1995).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"227_CR57","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.jaci.2017.09.041","volume":"141","author":"A Renand","year":"2018","unstructured":"Renand, A. et al. Synchronous immune alterations mirror clinical response during allergen immunotherapy. J. Allergy Clin. Immunol. 141, 1750\u20131760 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR58","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/cea.12780","volume":"46","author":"AO Eifan","year":"2016","unstructured":"Eifan, A. O. & Durham, S. R. Pathogenesis of rhinitis. Clin. Exp. Allergy 46, 1139\u20131151 (2016). This review illustrates key concepts of the pathogenesis of different forms of rhinitis. Environmental factors in association with imbalance in innate and adaptive immunity factors are likely to play major roles. Evidence for nasal priming and remodelling in AR are reviewed. Local AR in the absence of systemic IgE is discussed. Non-allergic (non-IgE-mediated) rhinitis is considered.","journal-title":"Clin. Exp. Allergy"},{"key":"227_CR59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM198507113130201","volume":"313","author":"RM Naclerio","year":"1985","unstructured":"Naclerio, R. M. et al. Inflammatory mediators in late antigen-induced rhinitis. N. Engl. J. Med. 313, 65\u201370 (1985).","journal-title":"N. Engl. J. Med."},{"key":"227_CR60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0021-8707(69)90018-5","volume":"43","author":"JT Connell","year":"1969","unstructured":"Connell, J. T. Quantitative intranasal pollen challenges: III. The priming effect in allergic rhinitis. J. Allergy 43, 33\u201344 (1969).","journal-title":"J. Allergy"},{"key":"227_CR61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaci.2003.09.047","volume":"113","author":"J Bousquet","year":"2004","unstructured":"Bousquet, J., Jacquot, W., Vignola, A. M., Bachert, C. & Van Cauwenberge, P. Allergic rhinitis: a disease remodeling the upper airways? J. Allergy Clin. Immunol. 113, 43\u201349 (2004).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR62","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/0091-6749(89)90362-X","volume":"84","author":"M Wachs","year":"1989","unstructured":"Wachs, M. et al. Observations on the pathogenesis of nasal priming. J. Allergy Clin. Immunol. 84, 492\u2013501 (1989).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR63","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-immunol-041015-055531","volume":"35","author":"F Weisel","year":"2017","unstructured":"Weisel, F., Shlomchik, M. & Memory, B. Cells of mice and humans. Annu. Rev. Immunol. 35, 255\u2013284 (2017).","journal-title":"Annu. Rev. Immunol."},{"key":"227_CR64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.it.2018.11.001","volume":"40","author":"MJ Schuijs","year":"2019","unstructured":"Schuijs, M. J., Hammad, H. & Lambrecht, B. N. Professional and \u2018amateur\u2019 antigen-presenting cells in type 2 immunity. Trends Immunol. 40, 22\u201334 (2019).","journal-title":"Trends Immunol."},{"key":"227_CR65","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jaci.2006.09.013","volume":"118","author":"S Sarin","year":"2006","unstructured":"Sarin, S., Undem, B., Sanico, A. & Togias, A. The role of the nervous system in rhinitis. J. Allergy Clin. Immunol. 118, 999\u20131016 (2006).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR66","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/chemse\/bjz042","volume":"44","author":"J Chen","year":"2019","unstructured":"Chen, J. et al. Expression of bitter taste receptors and solitary chemosensory cell markers in the human sinonasal cavity. Chem. Senses 44, 483\u2013495 (2019).","journal-title":"Chem. Senses"},{"key":"227_CR67","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0091-6749(93)90043-F","volume":"92","author":"BL Mosimann","year":"1993","unstructured":"Mosimann, B. L. et al. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J. Allergy Clin. Immunol. 92, 95\u2013104 (1993).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR68","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jaci.2013.11.027","volume":"133","author":"BJ Undem","year":"2014","unstructured":"Undem, B. J. & Taylor-Clark, T. Mechanisms underlying the neuronal-based symptoms of allergy. J. Allergy Clin. Immunol. 133, 1521\u20131534 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR69","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1164\/ajrccm.161.5.9908028","volume":"161","author":"AM Sanico","year":"2000","unstructured":"Sanico, A. M. et al. Nerve growth factor expression and release in allergic inflammatory disease of the upper airways. Am. J. Respir. Crit. Care Med. 161, 1631\u20131635 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"227_CR70","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaci.2006.04.037","volume":"118","author":"X Wu","year":"2006","unstructured":"Wu, X., Myers, A. C., Goldstone, A. C., Togias, A. & Sanico, A. M. Localization of nerve growth factor and its receptors in the human nasal mucosa. J. Allergy Clin. Immunol. 118, 428\u2013433 (2006).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR71","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1398-9995.2012.02822.x","volume":"67","author":"B Samolinski","year":"2012","unstructured":"Samolinski, B. et al. Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy 67, 726\u2013731 (2012).","journal-title":"Allergy"},{"key":"227_CR72","doi-asserted-by":"crossref","DOI":"10.1186\/2045-7022-1-2","volume":"1","author":"G Scadding","year":"2011","unstructured":"Scadding, G. et al. Diagnostic tools in rhinology EAACI position paper. Clin. Transl. Allergy 1, 2 (2011). A panel of European experts in the field of rhinology contributed to this consensus document on diagnostic tools in rhinology. This EAACI Task Force document aims at providing readers with a comprehensive and complete overview of currently available tools for diagnosis of nasal and sinonasal disease. The different important issues related to history taking, clinical examination and additional investigative tools for evaluation of the severity of sinonasal disease are logically ordered into a consensus document.","journal-title":"Clin. Transl. Allergy"},{"key":"227_CR73","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","volume":"108","author":"J Bousquet","year":"2001","unstructured":"Bousquet, J., Van Cauwenberge, P. & Khaltaev, N. Allergic rhinitis and its impact on asthma. J. Allergy Clin. Immunol. 108, S147\u2013334 (2001).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR74","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaci.2007.04.006","volume":"120","author":"A Valero","year":"2007","unstructured":"Valero, A. et al. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the allergic rhinitis and its impact on asthma severity items. J. Allergy Clin. Immunol. 120, 359\u2013365 (2007).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR75","doi-asserted-by":"crossref","DOI":"10.1186\/s13601-018-0210-2","volume":"8","author":"C Bachert","year":"2018","unstructured":"Bachert, C., Bousquet, J. & Hellings, P. Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management. Clin. Transl. Allergy 8, 25 (2018).","journal-title":"Clin. Transl. Allergy"},{"key":"227_CR76","doi-asserted-by":"crossref","DOI":"10.1186\/s13601-017-0153-z","volume":"7","author":"C Cingi","year":"2017","unstructured":"Cingi, C. et al. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology task force report. Clin. Transl. Allergy 7, 17 (2017). This report prepared by the EAACI Task Force on Allergic Rhinitis Comorbidities aims to highlight the role of multimorbidities in the definition, classification, mechanisms, recommendations for diagnosis and treatment of AR, and to define the needs in this neglected area by a literature review.","journal-title":"Clin. Transl. Allergy"},{"key":"227_CR77","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/cea.12104","volume":"43","author":"IJ Skypala","year":"2013","unstructured":"Skypala, I. J. et al. The prevalence of PFS and prevalence and characteristics of reported food allergy; a survey of UK adults aged 18\u201375 incorporating a validated PFS diagnostic questionnaire. Clin. Exp. Allergy 43, 928\u2013940 (2013).","journal-title":"Clin. Exp. Allergy"},{"key":"227_CR78","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/alr.21430","volume":"5","author":"DJ Mener","year":"2015","unstructured":"Mener, D. J., Shargorodsky, J., Varadhan, R. & Lin, S. Y. Topical intranasal corticosteroids and growth velocity in children: a meta-analysis. Int. Forum Allergy Rhinol. 5, 95\u2013103 (2015).","journal-title":"Int. Forum Allergy Rhinol."},{"key":"227_CR79","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/cea.12953","volume":"47","author":"GK Scadding","year":"2017","unstructured":"Scadding, G. K. et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (revised edition 2017; first edition 2007). Clin. Exp. Allergy 47, 856\u2013889 (2017).","journal-title":"Clin. Exp. Allergy"},{"key":"227_CR80","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/pharmacy8020085","volume":"8","author":"O Lourenco","year":"2020","unstructured":"Lourenco, O. et al. Managing allergic rhinitis in the pharmacy: an ARIA guide for implementation in practice. Pharmacy 8, 85 (2020).","journal-title":"Pharmacy"},{"key":"227_CR81","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4193\/Rhino14.074","volume":"53","author":"H Petersen","year":"2015","unstructured":"Petersen, H. et al. Manifestation of eosinophilic granulomatosis with polyangiitis in head and neck. Rhinology 53, 277\u2013285 (2015).","journal-title":"Rhinology"},{"key":"227_CR82","volume":"13","author":"IJ Ansotegui","year":"2020","unstructured":"Ansotegui, I. J. et al. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organ. J. 13, 100080 (2020).","journal-title":"World Allergy Organ. J."},{"key":"227_CR83","doi-asserted-by":"publisher","DOI":"10.1111\/all.14329","author":"L Klimek","year":"2020","unstructured":"Klimek, L. et al. In-vivo diagnostic test allergens in Europe: a call to action and proposal for recovery plan - an EAACI position paper. Allergy https:\/\/doi.org\/10.1111\/all.14329 (2020).","journal-title":"Allergy"},{"key":"227_CR84","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13223-016-0126-0","volume":"12","author":"IF Nevis","year":"2016","unstructured":"Nevis, I. F., Binkley, K. & Kabali, C. Diagnostic accuracy of skin-prick testing for allergic rhinitis: a systematic review and meta-analysis. Allergy Asthma Clin. Immunol. 12, 20 (2016).","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"227_CR85","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/pai.13036","volume":"30","author":"F Cipriani","year":"2019","unstructured":"Cipriani, F. et al. Early molecular biomarkers predicting the evolution of allergic rhinitis and its comorbidities: a longitudinal multicenter study of a patient cohort. Pediatr. Allergy Immunol. 30, 325\u2013334 (2019).","journal-title":"Pediatr. Allergy Immunol."},{"key":"227_CR86","volume":"13","author":"Steering Committee Authors & Review Panel Members.","year":"2020","unstructured":"Steering Committee Authors and Review Panel Members. A WAO \u2013 ARIA \u2013 GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): update 2020. World Allergy Organ. J. 13, 100091 (2020).","journal-title":"World Allergy Organ. J."},{"key":"227_CR87","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jaci.2020.01.006","volume":"145","author":"M Westman","year":"2020","unstructured":"Westman, M. et al. Sensitization to grass pollen allergen molecules in a birth cohort-natural Phl p 4 as an early indicator of grass pollen allergy. J. Allergy Clin. Immunol. 145, 1174\u20131181 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR88","first-page":"169","volume":"30","author":"JN Romero","year":"1992","unstructured":"Romero, J. N. & Scadding, G. Eosinophilia in nasal secretions compared to skin prick test and nasal challenge test in the diagnosis of nasal allergy. Rhinology 30, 169\u2013175 (1992).","journal-title":"Rhinology"},{"key":"227_CR89","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jaip.2019.12.017","volume":"8","author":"C Liu","year":"2020","unstructured":"Liu, C. et al. Use of nasal nitric oxide in the diagnosis of allergic rhinitis and nonallergic rhinitis in patients with and without sinus inflammation. J. Allergy Clin. Immunol. Pract. 8, 1574\u20131581 (2020).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"227_CR90","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/cea.13192","volume":"49","author":"P Campo","year":"2019","unstructured":"Campo, P. et al. Local allergic rhinitis: implications for management. Clin. Exp. Allergy 49, 6\u201316 (2019).","journal-title":"Clin. Exp. Allergy"},{"key":"227_CR91","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/all.13272","volume":"73","author":"C Rondon","year":"2018","unstructured":"Rondon, C. et al. Local allergic rhinitis is an independent rhinitis phenotype: the results of a 10-year follow-up study. Allergy 73, 470\u2013478 (2018).","journal-title":"Allergy"},{"key":"227_CR92","volume":"9","author":"F Raciborski","year":"2019","unstructured":"Raciborski, F. et al. Correction to: dissociating polysensitization and multimorbidity in children and adults from a Polish general population cohort. Clin. Transl. Allergy 9, 23 (2019).","journal-title":"Clin. Transl. Allergy"},{"key":"227_CR93","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.coi.2019.08.001","volume":"60","author":"J Deckers","year":"2019","unstructured":"Deckers, J., Lambrecht, B. N. & Hammad, H. How a farming environment protects from atopy. Curr. Opin. Immunol. 60, 163\u2013169 (2019).","journal-title":"Curr. Opin. Immunol."},{"key":"227_CR94","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2019.07.048","volume":"145","author":"ME Levin","year":"2020","unstructured":"Levin, M. E. et al. Environmental factors associated with allergy in urban and rural children from the South African Food Allergy (SAFFA) cohort. J. Allergy Clin. Immunol. 145, 415\u2013426 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR95","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/j.1398-9995.2008.01790.x","volume":"63","author":"E Eller","year":"2008","unstructured":"Eller, E. et al. Meta-analysis of determinants for pet ownership in 12 European birth cohorts on asthma and allergies: a GA2LEN initiative. Allergy 63, 1491\u20131498 (2008).","journal-title":"Allergy"},{"key":"227_CR96","volume":"9","author":"CA Cuello-Garcia","year":"2016","unstructured":"Cuello-Garcia, C. A. et al. World allergy organization-McMaster university guidelines for allergic disease prevention (GLAD-P): prebiotics. World Allergy Organ. J. 9, 10 (2016).","journal-title":"World Allergy Organ. J."},{"key":"227_CR97","volume":"8","author":"A Fiocchi","year":"2015","unstructured":"Fiocchi, A. et al. World allergy organization-McMaster university guidelines for allergic disease prevention (GLAD-P): probiotics. World Allergy Organ J. 8, 4 (2015).","journal-title":"World Allergy Organ J."},{"key":"227_CR98","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1398-9995.1993.tb02401.x","volume":"48","author":"J Bousquet","year":"1993","unstructured":"Bousquet, J. et al. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study. Allergy 48, 327\u2013333 (1993).","journal-title":"Allergy"},{"key":"227_CR99","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/archdischild-2014-306300","volume":"100","author":"GK Scadding","year":"2015","unstructured":"Scadding, G. K. Optimal management of allergic rhinitis. Arch. Dis. Child 100, 576\u2013582 (2015).","journal-title":"Arch. Dis. Child"},{"key":"227_CR100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2332\/allergolint.55.379","volume":"55","author":"K Okubo","year":"2006","unstructured":"Okubo, K., Ogino, S., Nagakura, T. & Ishikawa, T. Omalizumab is effective and safe in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis. Allergol. Int. 55, 379\u2013386 (2006).","journal-title":"Allergol. Int."},{"key":"227_CR101","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1398-9995.2011.02752.x","volume":"67","author":"U Nurmatov","year":"2012","unstructured":"Nurmatov, U., van Schayck, C. P., Hurwitz, B. & Sheikh, A. House dust mite avoidance measures for perennial allergic rhinitis: an updated Cochrane systematic review. Allergy 67, 158\u2013165 (2012).","journal-title":"Allergy"},{"issue":"Suppl 107","key":"227_CR102","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/all.14013","volume":"74","author":"E Satyaraj","year":"2019","unstructured":"Satyaraj, E., Wedner, H. J. & Bousquet, J. Keep the cat, change the care pathway: a transformational approach to managing Fel d 1, the major cat allergen. Allergy 74 (Suppl 107), 5\u201317 (2019).","journal-title":"Allergy"},{"key":"227_CR103","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/ijms20010213","volume":"20","author":"H Kawauchi","year":"2019","unstructured":"Kawauchi, H., Yanai, K., Wang, D. Y., Itahashi, K. & Okubo, K. Antihistamines for allergic rhinitis treatment from the viewpoint of nonsedative properties. Int. J. Mol. Sci. 20, 213 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"227_CR104","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2010.06.047","volume":"126","author":"JL Brozek","year":"2010","unstructured":"Brozek, J. L. et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J. Allergy Clin. Immunol. 126, 466\u2013476 (2010). The GRADE approach is used to propose recommendations for some recent information published on the pharmacological treatment of AR.","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR105","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1398-9995.2009.02325.x","volume":"65","author":"MK Church","year":"2010","unstructured":"Church, M. K. et al. Risk of first-generation H1-antihistamines: a GA2LEN position paper. Allergy 65, 459\u2013466 (2010).","journal-title":"Allergy"},{"key":"227_CR106","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMra033121","volume":"351","author":"FE Simons","year":"2004","unstructured":"Simons, F. E. Advances in H1-antihistamines. N. Engl. J. Med. 351, 2203\u20132217 (2004).","journal-title":"N. Engl. J. Med."},{"key":"227_CR107","first-page":"105","volume":"3","author":"S Kar","year":"2012","unstructured":"Kar, S., Krishnan, A., Preetha, K. & Mohankar, A. A review of antihistamines used during pregnancy. J. Pharmacol. Pharmacother. 3, 105\u2013108 (2012).","journal-title":"J. Pharmacol. Pharmacother."},{"key":"227_CR108","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2500\/ajr.2007.21.3058","volume":"21","author":"P Patel","year":"2007","unstructured":"Patel, P., D\u2019Andrea, C. & Sacks, H. J. Onset of action of azelastine nasal spray compared with mometasone nasal spray and placebo in subjects with seasonal allergic rhinitis evaluated in an environmental exposure chamber. Am. J. Rhinol. 21, 499\u2013503 (2007).","journal-title":"Am. J. Rhinol."},{"key":"227_CR109","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2222.2010.03654.x","volume":"41","author":"GJ Rodrigo","year":"2011","unstructured":"Rodrigo, G. J. & Neffen, H. Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review. Clin. Exp. Allergy 41, 160\u2013170 (2011).","journal-title":"Clin. Exp. Allergy"},{"key":"227_CR110","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ACI.0000000000000375","volume":"17","author":"DV Wallace","year":"2017","unstructured":"Wallace, D. V. & Dykewicz, M. S. Comparing the evidence in allergic rhinitis guidelines. Curr. Opin. Allergy Clin. Immunol. 17, 286\u2013294 (2017).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"227_CR111","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/0194599819832277","volume":"161","author":"EL Wu","year":"2019","unstructured":"Wu, E. L. et al. Epistaxis risk associated with intranasal corticosteroid sprays: a systematic review and meta-analysis. Otolaryngol. Head Neck Surg. 161, 18\u201327 (2019).","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"227_CR112","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/lary.27209","volume":"129","author":"CV Valenzuela","year":"2019","unstructured":"Valenzuela, C. V. et al. Intranasal corticosteroids do not lead to ocular changes: a systematic review and meta-analysis. Laryngoscope 129, 6\u201312 (2019).","journal-title":"Laryngoscope"},{"key":"227_CR113","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00405-017-4785-3","volume":"275","author":"AH Alhussien","year":"2018","unstructured":"Alhussien, A. H., Alhedaithy, R. A. & Alsaleh, S. A. Safety of intranasal corticosteroid sprays during pregnancy: an updated review. Eur. Arch. Otorhinolaryngol. 275, 325\u2013333 (2018).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"227_CR114","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.anai.2010.06.008","volume":"105","author":"FC Hampel","year":"2010","unstructured":"Hampel, F. C. et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann. Allergy Asthma Immunol. 105, 168\u2013173 (2010).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"227_CR115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2500\/aap.2019.40.4233","volume":"40","author":"N Segall","year":"2019","unstructured":"Segall, N., Prenner, B., Lumry, W., Caracta, C. F. & Tantry, S. K. Long-term safety and efficacy of olopatadine-mometasone combination nasal spray in patients with perennial allergic rhinitis. Allergy Asthma Proc. 40, 301\u2013310 (2019).","journal-title":"Allergy Asthma Proc."},{"key":"227_CR116","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.jaip.2018.01.031","volume":"6","author":"J Bousquet","year":"2018","unstructured":"Bousquet, J. et al. Onset of action of the fixed combination intranasal azelastine-fluticasone propionate in an allergen exposure chamber. J. Allergy Clin. Immunol. Pract. 6, 1726\u20131732 (2018).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"227_CR117","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.anai.2018.10.011","volume":"122","author":"P Patel","year":"2019","unstructured":"Patel, P., Salapatek, A. M. & Tantry, S. K. Effect of olopatadine-mometasone combination nasal spray on seasonal allergic rhinitis symptoms in an environmental exposure chamber study. Ann. Allergy Asthma Immunol. 122, 160\u2013166 (2019).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"227_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.03.050","author":"JL Brozek","year":"2017","unstructured":"Brozek, J. L. et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines - 2016 revision. J. Allergy Clin. Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2017.03.050 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR119","doi-asserted-by":"publisher","DOI":"10.7326\/M17-2203","author":"DV Wallace","year":"2017","unstructured":"Wallace, D. V., Dykewicz, M. S., Oppenheimer, J., Portnoy, J. M. & Lang, D. M. Pharmacologic treatment of seasonal allergic rhinitis: synopsis of guidance from the 2017 joint task force on practice parameters. Ann. Intern. Med. https:\/\/doi.org\/10.7326\/M17-2203 (2017). The GRADE approach is used to propose recommendations for some recent information published on the pharmacological treatment of AR. For the first time similar US and ARIA recommendations are published.","journal-title":"Ann. Intern. Med."},{"key":"227_CR120","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.2500\/ajra.2012.26.3787","volume":"26","author":"KE Hermelingmeier","year":"2012","unstructured":"Hermelingmeier, K. E., Weber, R. K., Hellmich, M., Heubach, C. P. & Mosges, R. Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta-analysis. Am. J. Rhinol. Allergy 26, e119\u2013e125 (2012).","journal-title":"Am. J. Rhinol. Allergy"},{"key":"227_CR121","first-page":"CD012597","volume":"6","author":"K Head","year":"2018","unstructured":"Head, K. et al. Saline irrigation for allergic rhinitis. Cochrane Database Syst. Rev. 6, CD012597 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"227_CR122","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40816-018-0080-0","volume":"4","author":"V Kozlov","year":"2018","unstructured":"Kozlov, V., Lavrenova, G., Savlevich, E. & Bazarkina, K. Evidence-based phytotherapy in allergic rhinitis. Clin. Phytosci. 4, 23 (2018).","journal-title":"Clin. Phytosci."},{"issue":"Suppl 100","key":"227_CR123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/all.12531","volume":"70","author":"J Mullol","year":"2015","unstructured":"Mullol, J. et al. Update on rupatadine in the management of allergic disorders. Allergy 70 (Suppl 100), 1\u201324 (2015).","journal-title":"Allergy"},{"key":"227_CR124","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2500\/aap.2017.38.4050","volume":"38","author":"AS Nayak","year":"2017","unstructured":"Nayak, A. S. et al. Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis. Allergy Asthma Proc. 38, 222\u2013230 (2017).","journal-title":"Allergy Asthma Proc."},{"key":"227_CR125","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/pai.12540","volume":"27","author":"W Berger","year":"2016","unstructured":"Berger, W. et al. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: importance of paediatric symptom assessment. Pediatr. Allergy Immunol. 27, 126\u2013133 (2016).","journal-title":"Pediatr. Allergy Immunol."},{"key":"227_CR126","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2500\/ajra.2013.27.3927","volume":"27","author":"RA Settipane","year":"2013","unstructured":"Settipane, R. A. & Kaliner, M. A. Chapter 14: nonallergic rhinitis. Am. J. Rhinol. Allergy 27, 48\u201351 (2013).","journal-title":"Am. J. Rhinol. Allergy"},{"key":"227_CR127","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40266-016-0425-7","volume":"34","author":"A Bozek","year":"2017","unstructured":"Bozek, A. Pharmacological management of allergic rhinitis in the elderly. Drugs Aging 34, 21\u201328 (2017).","journal-title":"Drugs Aging"},{"key":"227_CR128","first-page":"465","volume":"17","author":"MA Kaliner","year":"2002","unstructured":"Kaliner, M. A. H1-antihistamines in the elderly. Clin. Allergy Immunol. 17, 465\u2013481 (2002).","journal-title":"Clin. Allergy Immunol."},{"issue":"Suppl 1","key":"227_CR129","first-page":"1","volume":"23","author":"I Davila","year":"2013","unstructured":"Davila, I. et al. Use of second generation H1 antihistamines in special situations. J. Investig. Allergol Clin. Immunol. 23 (Suppl 1), 1\u201316 (2013).","journal-title":"J. Investig. Allergol Clin. Immunol."},{"key":"227_CR130","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/all.13701","volume":"74","author":"S Bosnic-Anticevich","year":"2019","unstructured":"Bosnic-Anticevich, S. et al. ARIA pharmacy 2018 \u201cAllergic rhinitis care pathways for community pharmacy\u201d: AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Sante) POLLAR (Impact of air pollution on asthma and rhinitis) GARD Demonstration project. Allergy 74, 1219\u20131236 (2019). Guidance for pharmacists to manage AR is proposed.","journal-title":"Allergy"},{"key":"227_CR131","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/cea.13333","volume":"49","author":"E Menditto","year":"2019","unstructured":"Menditto, E. et al. Adherence to treatment in allergic rhinitis using mobile technology. The MASK study. Clin. Exp. Allergy 49, 442\u2013460 (2019).","journal-title":"Clin. Exp. Allergy"},{"key":"227_CR132","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2019.01.053","volume":"144","author":"A Bedard","year":"2019","unstructured":"Bedard, A. et al. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: the MASK study. J. Allergy Clin. Immunol. 144, 135\u2013143 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR133","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1398-9995.2007.01560.x","volume":"63","author":"JL Brozek","year":"2008","unstructured":"Brozek, J. L. et al. Methodology for development of the allergic rhinitis and its impact on asthma guideline 2008 update. Allergy 63, 38\u201346 (2008).","journal-title":"Allergy"},{"key":"227_CR134","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaci.2019.06.049","volume":"145","author":"J Bousquet","year":"2020","unstructured":"Bousquet, J. et al. Next-generation Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J. Allergy Clin. Immunol. 145, 70\u201380 e73 (2020).This is the first report for any disease combining evidence-based medicine using the GRADE approach and real-world evidence (real-world data using mobile technology and chamber studies to assess the speed of onset of medications). Next-generation guidelines differ from the GRADE recommendations.","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR135","volume":"9","author":"J Bousquet","year":"2019","unstructured":"Bousquet, J. et al. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clin. Transl. Allergy 9, 16 (2019).","journal-title":"Clin. Transl. Allergy"},{"key":"227_CR136","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01023-2019","author":"J Bousquet","year":"2019","unstructured":"Bousquet, J. et al. From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity. Eur. Respir. J. https:\/\/doi.org\/10.1183\/13993003.01023-2019 (2019).","journal-title":"Eur. Respir. J."},{"key":"227_CR137","volume":"9","author":"JJ Bousquet","year":"2019","unstructured":"Bousquet, J. J. et al. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clin. Transl. Allergy 9, 44 (2019).","journal-title":"Clin. Transl. Allergy"},{"key":"227_CR138","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/all.13805","volume":"74","author":"J Bousquet","year":"2019","unstructured":"Bousquet, J. et al. 2019 ARIA care pathways for allergen immunotherapy. Allergy 74, 2087\u20132102 (2019).","journal-title":"Allergy"},{"key":"227_CR139","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/ACI.0000000000000585","volume":"19","author":"M Penagos","year":"2019","unstructured":"Penagos, M. & Durham, S. R. Duration of allergen immunotherapy for inhalant allergy. Curr. Opin. Allergy Clin. Immunol. 19, 594\u2013605 (2019).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"227_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.02.023","author":"H Sharif","year":"2019","unstructured":"Sharif, H. et al. Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: a randomized, double-blind, placebo-controlled trial. J. Allergy Clin. Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2019.02.023 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR141","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jaci.2018.09.039","volume":"143","author":"MH Shamji","year":"2019","unstructured":"Shamji, M. H. et al. Nasal allergen-neutralizing IgG4 antibodies block IgE-mediated responses: novel biomarker of subcutaneous grass pollen immunotherapy. J. Allergy Clin. Immunol. 143, 1067\u20131076 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR142","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/all.13213","volume":"73","author":"S Zielen","year":"2018","unstructured":"Zielen, S., Devillier, P., Heinrich, J., Richter, H. & Wahn, U. Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: a retrospective, real-world database analysis. Allergy 73, 165\u2013177 (2018).","journal-title":"Allergy"},{"key":"227_CR143","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000381059","volume":"166","author":"Y Okamoto","year":"2015","unstructured":"Okamoto, Y. et al. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis. Int. Arch. Allergy Immunol. 166, 177\u2013188 (2015).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"227_CR144","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jaip.2018.11.044","volume":"7","author":"M Gotoh","year":"2019","unstructured":"Gotoh, M. et al. Long-term efficacy and dose-finding trial of Japanese cedar pollen sublingual immunotherapy tablet. J. Allergy Clin. Immunol. Pract. 7, 1287\u20131297 (2019).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"227_CR145","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2016.3964","volume":"315","author":"JC Virchow","year":"2016","unstructured":"Virchow, J. C. et al. Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial. JAMA 315, 1715\u20131725 (2016).","journal-title":"JAMA"},{"key":"227_CR146","doi-asserted-by":"crossref","DOI":"10.1186\/s40413-015-0078-8","volume":"8","author":"C Bachert","year":"2015","unstructured":"Bachert, C. et al. Allergen immunotherapy on the way to product-based evaluation-a WAO statement. World Allergy Organ J. 8, 29 (2015).","journal-title":"World Allergy Organ J."},{"key":"227_CR147","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/ACI.0000000000000579","volume":"19","author":"A Bonertz","year":"2019","unstructured":"Bonertz, A., Mahler, V. & Vieths, S. Manufacturing and quality assessment of allergenic extracts for immunotherapy: state of the art. Curr. Opin. Allergy Clin. Immunol. 19, 640\u2013645 (2019).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"227_CR148","doi-asserted-by":"crossref","DOI":"10.1186\/s13601-019-0285-4","volume":"9","author":"C Pitsios","year":"2019","unstructured":"Pitsios, C. et al. Contraindications to immunotherapy: a global approach. Clin. Transl. Allergy 9, 45 (2019).","journal-title":"Clin. Transl. Allergy"},{"key":"227_CR149","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s40629-014-0032-2","volume":"23","author":"O Pfaar","year":"2014","unstructured":"Pfaar, O. et al. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (OGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD). Allergo J. Int. 23, 282\u2013319 (2014).","journal-title":"Allergo J. Int."},{"key":"227_CR150","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/all.13420","volume":"73","author":"A Muraro","year":"2018","unstructured":"Muraro, A. et al. EAACI guidelines on allergen immunotherapy: executive statement. Allergy 73, 739\u2013743 (2018).","journal-title":"Allergy"},{"key":"227_CR151","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/all.13317","volume":"73","author":"G Roberts","year":"2018","unstructured":"Roberts, G. et al. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy 73, 765\u2013798 (2018).","journal-title":"Allergy"},{"key":"227_CR152","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/all.13749","volume":"74","author":"I Agache","year":"2019","unstructured":"Agache, I. et al. EAACI guidelines on allergen immunotherapy: house dust mite-driven allergic asthma. Allergy 74, 855\u2013873 (2019).","journal-title":"Allergy"},{"key":"227_CR153","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.010","volume":"140","author":"MH Shamji","year":"2017","unstructured":"Shamji, M. H. & Durham, S. R. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. J. Allergy Clin. Immunol. 140, 1485\u20131498 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR154","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","volume":"4","author":"US Department of Health and Human Services FDA Center for Drug Evaluation and Research, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research & US Department of Health and Human Services FDA Center for Devices and Radiological Health","year":"2006","unstructured":"US Department of Health and Human Services FDA Center for Drug Evaluation and Research, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research & US Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for Industry: patient reported outcome measures: use in medical product development to support labelling claims: draft guidance. Health Qual. Life Outcomes 4, 79 (2006).","journal-title":"Health Qual. Life Outcomes"},{"key":"227_CR155","unstructured":"Committee for medicinal products for human use (CHMP). Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. European Medicines Agency https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/reflection-paper-regulatory-guidance-use-healthrelated-quality-life-hrql-measures-evaluation_en.pdf (2005)."},{"key":"227_CR156","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1398-9995.2009.01973.x","volume":"64","author":"JL Brozek","year":"2009","unstructured":"Brozek, J. L. et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy 64, 669\u2013677 (2009).","journal-title":"Allergy"},{"key":"227_CR157","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1007\/s11136-013-0425-6","volume":"22","author":"MA Sprangers","year":"2013","unstructured":"Sprangers, M. A., Hall, P., Morisky, D. E., Narrow, W. E. & Dapueto, J. Using patient-reported measurement to pave the path towards personalized medicine. Qual. Life Res. 22, 2631\u20132637 (2013).","journal-title":"Qual. Life Res."},{"key":"227_CR158","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1164\/ajrccm.162.4.9912033","volume":"162","author":"B Leynaert","year":"2000","unstructured":"Leynaert, B., Neukirch, C., Liard, R., Bousquet, J. & Neukirch, F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am. J. Respir. Crit. Care Med. 162, 1391\u20131396 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"227_CR159","first-page":"457","volume":"98","author":"P Sritipsukho","year":"2015","unstructured":"Sritipsukho, P. & Viriyaudomsir, O. Health-related quality of life in Thai children with allergic respiratory diseases. J. Med. Assoc. Thai. 98, 457\u2013463 (2015).","journal-title":"J. Med. Assoc. Thai."},{"key":"227_CR160","first-page":"222","volume":"33","author":"P Sritipsukho","year":"2015","unstructured":"Sritipsukho, P., Satdhabudha, A. & Nanthapisal, S. Effect of allergic rhinitis and asthma on the quality of life in young Thai adolescents. Asian Pac. J. Allergy Immunol. 33, 222\u2013226 (2015).","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"227_CR161","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11882-012-0334-8","volume":"13","author":"DA Dietz de Loos","year":"2013","unstructured":"Dietz de Loos, D. A., Segboer, C. L., Gevorgyan, A. & Fokkens, W. J. Disease-specific quality-of-life questionnaires in rhinitis and rhinosinusitis: review and evaluation. Curr. Allergy Asthma Rep. 13, 162\u2013170 (2013).","journal-title":"Curr. Allergy Asthma Rep."},{"key":"227_CR162","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.jaip.2019.01.015","volume":"7","author":"MA Calderon","year":"2019","unstructured":"Calderon, M. A., Casale, T. B. & Demoly, P. Validation of patient-reported outcomes for clinical trials in allergic rhinitis: a systematic review. J. Allergy Clin. Immunol. Pract. 7, 1450\u20131461 (2019).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"227_CR163","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.iac.2015.12.002","volume":"36","author":"EO Meltzer","year":"2016","unstructured":"Meltzer, E. O. Allergic rhinitis: burden of illness, quality of life, comorbidities, and control. Immunol. Allergy Clin. North. Am. 36, 235\u2013248 (2016).","journal-title":"Immunol. Allergy Clin. North. Am."},{"key":"227_CR164","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031178","volume":"7","author":"F Braido","year":"2012","unstructured":"Braido, F. et al. Patients with asthma and comorbid allergic rhinitis: is optimal quality of life achievable in real life? PLoS ONE 7, e31178 (2012).","journal-title":"PLoS ONE"},{"key":"227_CR165","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/pai.12667","volume":"28","author":"I Baiardini","year":"2017","unstructured":"Baiardini, I. et al. RHINASTHMA-children: a new quality of life tool for patients with respiratory allergy. Pediatr. Allergy Immunol. 28, 102\u2013105 (2017).","journal-title":"Pediatr. Allergy Immunol."},{"key":"227_CR166","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/pai.12242","volume":"25","author":"S La Grutta","year":"2014","unstructured":"La Grutta, S. et al. RHINASTHMA-adolescents: a new quality of life tool for patients with respiratory allergy. Pediatr. Allergy Immunol. 25, 450\u2013455 (2014).","journal-title":"Pediatr. Allergy Immunol."},{"key":"227_CR167","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000494507","volume":"178","author":"NI Ilyina","year":"2019","unstructured":"Ilyina, N. I. et al. Efficacy of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, delivered in a single spray, for the treatment of seasonal allergic rhinitis: results from Russia. Int. Arch. Allergy Immunol. 178, 255\u2013263 (2019).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"227_CR168","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1377\/hlthaff.2015.1362","volume":"35","author":"DC Lavallee","year":"2016","unstructured":"Lavallee, D. C. et al. Incorporating patient-reported outcomes into health care to engage patients and enhance care. Health Aff. 35, 575\u2013582 (2016).","journal-title":"Health Aff."},{"key":"227_CR169","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/jamia\/ocv085","volume":"23","author":"CA Harle","year":"2016","unstructured":"Harle, C. A. et al. Overcoming barriers to implementing patient-reported outcomes in an electronic health record: a case report. J. Am. Med. Inform. Assoc. 23, 74\u201379 (2016).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"227_CR170","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/all.12014","volume":"67","author":"F Braido","year":"2012","unstructured":"Braido, F. et al. RhinAsthma patient perspective: a short daily asthma and rhinitis QoL assessment. Allergy 67, 1443\u20131450 (2012).","journal-title":"Allergy"},{"key":"227_CR171","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/all.13953","volume":"75","author":"PM Matricardi","year":"2020","unstructured":"Matricardi, P. M. et al. The role of mobile health technologies in allergy care: an EAACI position paper. Allergy 75, 259\u2013272 (2020).","journal-title":"Allergy"},{"key":"227_CR172","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13052-020-00870-z","volume":"46","author":"S Tripodi","year":"2020","unstructured":"Tripodi, S. et al. Digital technologies for an improved management of respiratory allergic diseases: 10 years of clinical studies using an online platform for patients and physicians. Ital. J. Pediatr. 46, 105 (2020).","journal-title":"Ital. J. Pediatr."},{"key":"227_CR173","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.jaip.2019.07.044","volume":"7","author":"J Bousquet","year":"2019","unstructured":"Bousquet, J. et al. Mobile technology in allergic rhinitis: evolution in management or revolution in health and care? J. Allergy Clin. Immunol. Pract. 7, 2511\u20132523 (2019).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"227_CR174","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.7426","volume":"19","author":"K Bastl","year":"2017","unstructured":"Bastl, K., Berger, U. & Kmenta, M. Evaluation of pollen apps forecasts: the need for quality control in an eHealth service. J. Med. Internet Res. 19, e152 (2017).","journal-title":"J. Med. Internet Res."},{"key":"227_CR175","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000916","author":"M Sofiev","year":"2020","unstructured":"Sofiev, M. et al. A demonstration project of global alliance against chronic respiratory diseases: prediction of interactions between air pollution and allergen exposure-the Mobile Airways Sentinel Network-Impact of air pollution on asthma and rhinitis approach. Chin. Med. J. https:\/\/doi.org\/10.1097\/CM9.0000000000000916 (2020).","journal-title":"Chin. Med. J."},{"key":"227_CR176","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00102-2019","author":"Y Jiang","year":"2019","unstructured":"Jiang, Y. et al. Transcriptomics of atopy and atopic asthma in white blood cells from children and adolescents. Eur. Respir. J. https:\/\/doi.org\/10.1183\/13993003.00102-2019 (2019).","journal-title":"Eur. Respir. J."},{"key":"227_CR177","volume":"14","author":"D Aguilar","year":"2019","unstructured":"Aguilar, D. et al. Understanding allergic multimorbidity within the non-eosinophilic interactome. PLoS ONE 14, e0224448 (2019).","journal-title":"PLoS ONE"},{"key":"227_CR178","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/13543784.2019.1571581","volume":"28","author":"E Heffler","year":"2019","unstructured":"Heffler, E. et al. New drugs in early-stage clinical trials for allergic rhinitis. Expert Opin. Investig. Drugs 28, 267\u2013273 (2019).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"227_CR179","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/1945892419884774","volume":"34","author":"C Yu","year":"2020","unstructured":"Yu, C. et al. Clinical efficacy and safety of omalizumab in the treatment of allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials. Am. J. Rhinol. Allergy 34, 196\u2013208 (2020).","journal-title":"Am. J. Rhinol. Allergy"},{"key":"227_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.01.031","author":"GB Patel","year":"2020","unstructured":"Patel, G. B., Kern, R. C., Bernstein, J. A., Hae-Sim, P. & Peters, A. T. Current and future treatments of rhinitis and sinusitis. J. Allergy Clin. Immunol. Pract. https:\/\/doi.org\/10.1016\/j.jaip.2020.01.031 (2020).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"Suppl 108","key":"227_CR181","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/all.14077","volume":"74","author":"O Pfaar","year":"2019","unstructured":"Pfaar, O. et al. Perspectives in allergen immunotherapy: 2019 and beyond. Allergy 74 (Suppl 108), 3\u201325 (2019).","journal-title":"Allergy"},{"key":"227_CR182","doi-asserted-by":"publisher","DOI":"10.1111\/all.14300","author":"Y Dorofeeva","year":"2020","unstructured":"Dorofeeva, Y. et al. Past, presence and future of allergen immunotherapy vaccines. Allergy https:\/\/doi.org\/10.1111\/all.14300 (2020).","journal-title":"Allergy"},{"key":"227_CR183","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13588","author":"P Pechsrichuang","year":"2020","unstructured":"Pechsrichuang, P. & Jacquet, A. Molecular approaches to allergen-specific immunotherapy: are we so far from clinical implementation? Clin. Exp. Allergy https:\/\/doi.org\/10.1111\/cea.13588 (2020).","journal-title":"Clin. Exp. Allergy"},{"key":"227_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.03.029","author":"A Rodriguez-Dominguez","year":"2020","unstructured":"Rodriguez-Dominguez, A. et al. Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy. J. Allergy Clin. Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2020.03.029 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.iac.2019.09.010","volume":"40","author":"ZI Komlosi","year":"2020","unstructured":"Komlosi, Z. I. et al. Highlights of novel vaccination strategies in allergen immunotherapy. Immunol. Allergy Clin. North Am. 40, 15\u201324 (2020).","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"227_CR186","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jaci.2009.11.022","volume":"125","author":"M Massanari","year":"2010","unstructured":"Massanari, M. et al. Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma. J. Allergy Clin. Immunol. 125, 383\u2013389 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR187","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2500\/aap.2020.41.200041","volume":"41","author":"HS Nelson","year":"2020","unstructured":"Nelson, H. S. Allergy immunotherapy: future directions for the 2020s. Allergy Asthma Proc. 41, 314\u2013325 (2020).","journal-title":"Allergy Asthma Proc."},{"key":"227_CR188","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3389\/fimmu.2020.01368","volume":"11","author":"I Tulaeva","year":"2020","unstructured":"Tulaeva, I. et al. Preventive allergen-specific vaccination against allergy: mission possible? Front. Immunol. 11, 1368 (2020).","journal-title":"Front. Immunol."},{"key":"227_CR189","doi-asserted-by":"crossref","first-page":"1264717","DOI":"10.1080\/20016689.2017.1264717","volume":"5","author":"M Toumi","year":"2017","unstructured":"Toumi, M. & Remuzat, C. Value added medicines: what value repurposed medicines might bring to society? J. Mark Access Health Policy 5, 1264717 (2017).","journal-title":"J. Mark Access Health Policy"},{"key":"227_CR190","doi-asserted-by":"publisher","DOI":"10.1111\/all.14422","author":"J Bousquet","year":"2020","unstructured":"Bousquet, J. et al. ARIA digital anamorphosis: digital transformation of health and care in airway diseases from research to practice. Allergy https:\/\/doi.org\/10.1111\/all.14422 (2020).","journal-title":"Allergy"},{"key":"227_CR191","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12962-018-0095-x","volume":"16","author":"K Stenberg","year":"2018","unstructured":"Stenberg, K., Lauer, J. A., Gkountouras, G., Fitzpatrick, C. & Stanciole, A. Econometric estimation of WHO-CHOICE country-specific costs for inpatient and outpatient health service delivery. Cost Eff. Resour. Alloc. 16, 11 (2018).","journal-title":"Cost Eff. Resour. Alloc."},{"key":"227_CR192","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.socscimed.2012.09.026","volume":"75","author":"J Russell","year":"2012","unstructured":"Russell, J. & Greenhalgh, T. Affordability as a discursive accomplishment in a changing National Health Service. Soc. Sci. Med. 75, 2463\u20132471 (2012).","journal-title":"Soc. Sci. Med."},{"key":"227_CR193","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1108\/JHOM-01-2014-0019","volume":"29","author":"DJ Hunter","year":"2015","unstructured":"Hunter, D. J. et al. Doing transformational change in the English NHS in the context of \u201cbig bang\u201d redisorganisation. J. Health Organ. Manag. 29, 10\u201324 (2015).","journal-title":"J. Health Organ. Manag."},{"key":"227_CR194","doi-asserted-by":"crossref","first-page":"46958018757848","DOI":"10.1177\/0046958018757848","volume":"55","author":"E Farmanova","year":"2018","unstructured":"Farmanova, E., Bonneville, L. & Bouchard, L. Organizational health literacy: review of theories, frameworks, guides, and implementation issues. Inquiry 55, 46958018757848 (2018).","journal-title":"Inquiry"},{"key":"227_CR195","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jaci.2018.08.049","volume":"143","author":"J Bousquet","year":"2019","unstructured":"Bousquet, J. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) phase 4 (2018): change management in allergic rhinitis and asthma multimorbidity using mobile technology. J Allergy Clin. Immunol. 143, 864\u2013879 (2019).","journal-title":"J Allergy Clin. Immunol."},{"key":"227_CR196","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2222.1991.tb00807.x","volume":"21","author":"EF Juniper","year":"1991","unstructured":"Juniper, E. F. & Guyatt, G. H. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin. Exp. Allergy 21, 77\u201383 (1991).","journal-title":"Clin. Exp. Allergy"},{"key":"227_CR197","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1365-2222.2000.00668.x","volume":"30","author":"EF Juniper","year":"2000","unstructured":"Juniper, E. F., Thompson, A. K., Ferrie, P. J. & Roberts, J. N. Development and validation of the mini rhinoconjunctivitis quality of life questionnaire. Clin. Exp. Allergy 30, 132\u2013140 (2000).","journal-title":"Clin. Exp. Allergy"},{"key":"227_CR198","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1067\/mai.2003.137","volume":"111","author":"EF Juniper","year":"2003","unstructured":"Juniper, E. F., Rohrbaugh, T. & Meltzer, E. O. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J. Allergy Clin. Immunol. 111, 484\u2013490 (2003).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR199","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1034\/j.1398-9995.2003.00079.x","volume":"58","author":"I Baiardini","year":"2003","unstructured":"Baiardini, I. et al. Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 58, 289\u2013294 (2003).","journal-title":"Allergy"},{"key":"227_CR200","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0091-6749(94)90349-2","volume":"93","author":"EF Juniper","year":"1994","unstructured":"Juniper, E. F., Guyatt, G. H. & Dolovich, J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J. Allergy Clin. Immunol. 93, 413\u2013423 (1994).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR201","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0091-6749(98)70380-X","volume":"101","author":"EF Juniper","year":"1998","unstructured":"Juniper, E. F., Howland, W. C., Roberts, N. B., Thompson, A. K. & King, D. R. Measuring quality of life in children with rhinoconjunctivitis. J. Allergy Clin. Immunol. 101, 163\u2013170 (1998).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR202","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13599","author":"S Fasola","year":"2020","unstructured":"Fasola, S. et al. RAPP-children: a new tool for assessing quality of life in patients with asthma and rhinitis. Clin. Exp. Allergy https:\/\/doi.org\/10.1111\/cea.13599 (2020).","journal-title":"Clin. Exp. Allergy"},{"key":"227_CR203","doi-asserted-by":"crossref","first-page":"108427","DOI":"10.1016\/j.clim.2020.108427","volume":"215","author":"K Yuki","year":"2020","unstructured":"Yuki, K., Fujiogi, M. & Koutsogiannaki, S. COVID-19 pathophysiology: a review. Clin. Immunol. 215, 108427 (2020).","journal-title":"Clin. Immunol."},{"key":"227_CR204","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaci.2020.04.009","volume":"146","author":"D Jackson","year":"2020","unstructured":"Jackson, D. et al. Association of respiratory allergy, asthma and expression of the SARS-CoV-2 receptor, ACE2. J. Allergy Clin. Immunol. 146, 203\u2013206 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.05.004","author":"H Kimura","year":"2020","unstructured":"Kimura, H. et al. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells. J. Allergy Clin. Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.004 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.08.008","author":"JM Yang","year":"2020","unstructured":"Yang, J. M. et al. Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study. J. Allergy Clin. Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2020.08.008 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR207","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-05965-1","author":"JR Lechien","year":"2020","unstructured":"Lechien, J. R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur. Arch. Otorhinolaryngol. https:\/\/doi.org\/10.1007\/s00405-020-05965-1 (2020).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"227_CR208","doi-asserted-by":"publisher","DOI":"10.1111\/all.14453","author":"O Pfaar","year":"2020","unstructured":"Pfaar, O. et al. COVID-19 pandemic: practical considerations on the organization of an allergy clinic - an EAACI\/ARIA position paper. Allergy https:\/\/doi.org\/10.1111\/all.14453 (2020).","journal-title":"Allergy"},{"key":"227_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.anorl.2020.04.013","author":"T Radulesco","year":"2020","unstructured":"Radulesco, T. et al. COVID-19 and rhinology, from the consultation room to the operating theatre. Eur. Ann. Otorhinolaryngol. Head Neck Dis. https:\/\/doi.org\/10.1016\/j.anorl.2020.04.013 (2020).","journal-title":"Eur. Ann. Otorhinolaryngol. Head Neck Dis."},{"key":"227_CR210","doi-asserted-by":"publisher","DOI":"10.1111\/all.14449","author":"C Riggioni","year":"2020","unstructured":"Riggioni, C. et al. A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy https:\/\/doi.org\/10.1111\/all.14449 (2020).","journal-title":"Allergy"},{"key":"227_CR211","doi-asserted-by":"crossref","first-page":"738","DOI":"10.4168\/aair.2020.12.4.738","volume":"12","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. & Zhang, L. Management practice of allergic rhinitis in china during the COVID-19 pandemic. Allergy Asthma Immunol. Res. 12, 738\u2013742 (2020).","journal-title":"Allergy Asthma Immunol. Res."},{"key":"227_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.03.018","author":"CD Codispoti","year":"2020","unstructured":"Codispoti, C. D., Bandi, S., Moy, J. & Mahdavinia, M. Running a virtual allergy division and training program in the time of COVID-19 pandemic. J. Allergy Clin. Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2020.03.018 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"227_CR213","doi-asserted-by":"publisher","DOI":"10.1111\/all.14302","author":"J Bousquet","year":"2020","unstructured":"Bousquet, J. et al. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: an ARIA-EAACI statement. Allergy https:\/\/doi.org\/10.1111\/all.14302 (2020).","journal-title":"Allergy"},{"key":"227_CR214","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5414\/ALX02147E","volume":"4","author":"L Klimek","year":"2020","unstructured":"Klimek, L. et al. Allergen immunotherapy in the current COVID-19 pandemic: a position paper of AeDA, ARIA, EAACI, DGAKI and GPA: position paper of the German ARIA GroupA in cooperation with the Austrian ARIA GroupB, the Swiss ARIA GroupC, German Society for Applied Allergology (AEDA)D, German Society for Allergology and Clinical Immunology (DGAKI)E, Society for Pediatric Allergology (GPA)F in cooperation with AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHCG and the European Academy of Allergy and Clinical Immunology (EAACI)H. Allergol. Select. 4, 44\u201352 (2020).","journal-title":"Allergol. Select."},{"key":"227_CR215","doi-asserted-by":"publisher","DOI":"10.1111\/all.14336","author":"L Klimek","year":"2020","unstructured":"Klimek, L. et al. Handling of allergen immunotherapy in the COVID-19 pandemic: an ARIA-EAACI statement. Allergy https:\/\/doi.org\/10.1111\/all.14336 (2020).","journal-title":"Allergy"},{"key":"227_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.04.003","author":"G Malipiero","year":"2020","unstructured":"Malipiero, G. et al. An academic allergy unit during COVID-19 pandemic in Italy. J Allergy Clin. Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2020.04.003 (2020).","journal-title":"J Allergy Clin. Immunol."},{"key":"227_CR217","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.08.035","author":"AA Dror","year":"2020","unstructured":"Dror, A. A. et al. Reduction of allergic rhinitis symptoms with face mask usage during the COVID-19 pandemic. J. Allergy Clin. Immunol. Pract. https:\/\/doi.org\/10.1016\/j.jaip.2020.08.035 (2020).","journal-title":"J. Allergy Clin. Immunol. Pract."}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-020-00227-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-020-00227-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-020-00227-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:24:56Z","timestamp":1733941496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-020-00227-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":217,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["227"],"URL":"https:\/\/doi.org\/10.1038\/s41572-020-00227-0","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,3]]},"assertion":[{"value":"15 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.B. reports personal fees from Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Purina, Sanofi-Aventis, Takeda, Teva and Uriach and other fees from KYomed-Innov and MASK-air outside the submitted work. S.B.-A. reports grants from TEVA and personal fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Mylan, Sanofi and TEVA outside the submitted work. C.B. reports personal fees from ALK, Mylan, GlaxoSmithKline, Sanofi, Novartis and AstraZeneca. G.W.C. reports having received research grants as well as being a lecturer or having received advisory board fees from A.Menarini, ALK-Abell\u00f3, Allergy Therapeutics, AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, Genentech, Guidotti-Malesci, GlaxoSmithKline, Hal Allergy, Mylan, Merck, Merck Sharp & Dohme Mundipharma, Novartis, Regeneron, Roche, Sanofi-Aventis, Sanofi-Genzyme, Stallergenes-Greer, UCB Pharma, Uriach Pharma, Valeas and Vibor-Pharma. I.B reports personal fees from Menarini, Mundipharma, Novartis, GlaxoSmithKline, Sanofi-Genzyme, AstraZeneca and Boehringer Ingelheim outside the submitted work. E.M. reports personal fees from AstraZeneca, Chiesi, Novartis and Sanofi outside the submitted work. O.P. reports research grants from Inmunotek S.L. and Novartis and fees for giving scientific lectures from Allergy Therapeutics, Amgen, AstraZeneca, Diater, GlaxoSmithKline S.A., Inmunotek S.L., Novartis, Sanofi-Genzyme and Stallergenes, and has participated in advisory boards for Novartis and Sanofi-Genzyme. G.K.S. reports personal fees from ALK, Bayer, GlaxoSmithKline and Mylan, outside the submitted work, and is British Society for Allergy and Clinical Immunology Rhinitis Guidelines Chair and European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) Lead for allergic rhinitis. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}